Similarly, Proxetin, another formulation of probiotics, was found to effectively reduce the serum ALT and AST levels in patients suffering from NAFLD (Eslamparast et al., 2014). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.